Iuri Marinov

Interferon-alpha Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients

2016 | Přírodovědecká fakulta, 1. lékařská fakulta, 3. lékařská fakulta

Publikace